ReviewInternational journal of hematology2022

Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review.

Ayumu Ito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.